IDO1 and melanoma: Actually, IDO knockout mice with melanoma have longer survival than wild-type ones when treated with immunotherapy, while the combination of an IDO inhibitor with cytotoxic drugs like paclitaxel or with ICIs reduces tumor growth in mice with melanoma and BC [68,69].